Portfolio Thuja Capital Healthcare Fund II

Company: Atro Medical - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2017
Status: Active

Nijmegen based Radboudumc spin-off Atro Medical develops an anatomically shaped polymer based meniscus implant, the Trammpolin, with the aim of restoring the protective function of the meniscus by acting as a joint spacer.

Company: MILabs - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2016
Status: Active

MILabs is a company based in Utrecht, that develops and sells state of the art molecular imaging devices, for preclinical use. In addition, MILabs is developing a clinical SPECT scanner that will have unprecedented imaging capabilities, allowing doctors to make images well beyond what they can image today.

Company: Indigo Diabetes - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2016
Status: Active

Indigo Diabetes is a Belgian startup developing novel glucose sensor technology based on photonics, thus avoiding the need for frequent calibration

Company: NutriLeads - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2015
Status: Active

Wageningen based company active in the field of medical nutrition and functional foods. Currently develops a food ingredient with immune system enhancing properties to help combat infections.

Company: Encare Biotech - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2014
Status: Active

Encare Biotech is a spin-off of Utrecht UMC, dedicated to develop antibody therapeutics to prevent chronic heart failure as a consequence of a myocardial infarction.